Tag:innovation

The Bill & Melinda Gates Foundation announced today that they will commit $10 billion over the next 10 years to help research, develop and deliver vaccines for the world’s poorest countries.  The Foundation estimates that increased vaccination could save more than 8 million children by 2020.

“We must make this the decade of vaccines,” said Bill Gates. “Vaccines already save and improve millions of lives in developing countries. Innovation will make it possible to save more children than ever before.”

Read more...  

World Health Advocacy co-hosted the "Access to Rx Drugs:  What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009.  Elisabeth Fowler helped to moderate the workshop and also delivered the attached presentation, providing an overview of the process of medical innovation.

Read more...  

A majority of Canadians (73.1%) agree that the Government should strongly enforce intellectual property rights in relation to the development of new medicines. [1]

Read more...  

According to a recent survey [1], a majority of Canadians (77 per cent) recognize that innovation – in the medical field as well as other sectors – is essential to the future prosperity of the country. Canadians view encouraging new discoveries and innovations as a more important factor in economic prosperity than cutting business taxes or reducing red tape.

Read more...  

It is encouraging that multinational pharmaceutical companies are continuing to invest significantly in research into neglected diseases.

Read more...  

The World Health Organization (WHO), which has been intensely debating intellectual property (IP) rights issues, has restructured its management of the issues, elevating IP to the director general’s office. A new team for public health, innovation and intellectual property has been created. (1)

This move follows the close of the second meeting of the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG), which adjourned with no agreed strategy or plan of action amidst concerns raised by patient groups that the issue has become polarized and that the IGWG process has gone off-track.

Read more...  

In 2002 Canada‘s Patented Medicines Prices Review Board compared research and development spending by the innovative pharmaceutical industry in Canada with France, Germany, Italy, Sweden, Switzerland, the United Kingdom and the United States. It determined that although R&D spending in Canada has increased from 1995 to 2000, Canada’s ratio of R&D to domestic sales ranked behind all other industrialized countries, except Italy.

Read more...  

In order to boost the competitiveness of the European-based pharmaceutical industry “in line with the European Union’s health objectives”, the European commission announced plans that include:

  • Examining the scope “for improving delays generated by pricing and reimbursement decisions”
  • “Improving patient information, strengthening the role of patients in public health decision-making”
  • ”Establishing a level playing field on intellectual property protection and providing support to new Member States to implement the legislative framework”
Read more...  

Before a new drug is approved for use by patients, it must undergo rigorous testing and then be reviewed by regulatory agencies (Health Canada). In Canada, the review process for new drugs is much longer than in other developed countries. The result is that Canadian patients wait significantly longer than patients in other countries for access to new medicines.

Read more...  

The Medicare Modernization Act passed by Congress in 2003 instructed the Secretary of Commerce to conduct a study on OECD drug price controls and the implications for US consumers. The US Department of Commerce, International Trade Administration released the results of its study December 2004.

Read more...  
<< Start < Prev 1 2 Next > End >>
Powered by Tags for Joomla